Profile | GDS2987 / GI_34452710-A |
Title | Comparison of Rho kinase inhibitor and atorvastatin effects on primary cell lines |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM214810 | HMVEC_vehicle_rep1 | ||
GSM215244 | HMVEC_vehicle_rep2 | 9.5 | 25 |
GSM215253 | HMVEC_vehicle_rep3 | ||
GSM215254 | HMVEC_atorvastatin_rep1 | ||
GSM215282 | HMVEC_atorvastatin_rep3 | ||
GSM215344 | HMVEC_atorvastatin_rep2 | 10.8 | 27 |
GSM215283 | HMVEC_atorvastatin_mevalonate_rep1 | ||
GSM215284 | HMVEC_atorvastatin_mevalonate_rep2 | 2.1 | 5 |
GSM215293 | HMVEC_atorvastatin_mevalonate_rep3 | 6.8 | 12 |
GSM215294 | HMVEC_SLx2119_rep1 | 4 | 15 |
GSM215295 | HMVEC_SLx2119_rep2 | 4.9 | 10 |
GSM215296 | HMVEC_SLx2119_rep3 | ||
GSM215297 | PASMC_vehicle_rep1 | ||
GSM215298 | PASMC_vehicle_rep2 | 23.4 | 35 |
GSM215310 | PASMC_vehicle_rep3 | 49.2 | 60 |
GSM215311 | PASMC_atorvastatin_rep1 | 57.4 | 66 |
GSM215312 | PASMC_atorvastatin_rep2 | 50.7 | 60 |
GSM215313 | PASMC_atorvastatin_rep3 | 54.4 | 61 |
GSM215324 | PASMC_atorvastatin_mevalonate_rep1 | 7.5 | 13 |
GSM215325 | PASMC_atorvastatin_mevalonate_rep2 | 46.8 | 63 |
GSM215326 | PASMC_atorvastatin_mevalonate_rep3 | 44.8 | 59 |
GSM215327 | PASMC_SLx2119_rep1 | 46.4 | 60 |
GSM215328 | PASMC_SLx2119_rep2 | 43 | 59 |
GSM215329 | PASMC_SLx2119_rep3 | 40.7 | 59 |
GSM215330 | Fibroblasts_vehicle_rep1 | ||
GSM215331 | Fibroblasts_vehicle_rep2 | 5.5 | 16 |
GSM215332 | Fibroblasts_vehicle_rep3 | 2.8 | 10 |
GSM215333 | Fibroblasts_atorvastatin_rep1 | 1.7 | 5 |
GSM215334 | Fibroblasts_atorvastatin_rep2 | 17.4 | 44 |
GSM215335 | Fibroblasts_atorvastatin_rep3 | ||
GSM215336 | Fibroblasts_atorvastatin_mevalonate_rep1 | 2.8 | 10 |
GSM215337 | Fibroblasts_atorvastatin_mevalonate_rep2 | 9.1 | 29 |
GSM215338 | Fibroblasts_atorvastatin_mevalonate_rep3 | 2.4 | 7 |
GSM215339 | Fibroblasts_SLx2119_rep1 | ||
GSM215340 | Fibroblasts_SLx2119_rep2 | 24.8 | 55 |
GSM215341 | Fibroblasts_SLx2119_rep3 | 16.1 | 38 |